Skip to content
AwardedSpainGoods€1,477,586

PNSP 2025-1-603 (A/SUM-007784/2026) Suministro de Tofersen (QALSODY®) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos

Published
Published 27 May 2026

Overview

Hospital Clínico San Carlos procured the supply of Tofersen (QALSODY®) as an exclusive distribution pharmaceutical product for its pharmacy service. The contract was awarded to Biogen Spain S.L. on 21 May 2026 for a value of €903,935.03 against an estimated value of €1,477,586.11.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€1,477,586
Procedure
Direct
Published
27 May 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€903,935
Award date
21 May 2026
Contract period
— → 12 November 2027
Winner
  • BIOGEN SPAIN S.L

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    27 May 2026

Contracting authority

  • HOSPITAL CLINICO SAN CARLOS

    Procuring entity

    Madrid, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: PNSP 2025-1-603 (A/SUM-007784/2026) Suministro de Tofersen (QALSODY®) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos — won by BIOGEN SPAIN S.L — Skim